Using a harmless glucose solution, the procedure generates reliable results

May 2, 2023 — Metabolic disorders are involved in many common health conditions such as Alzheimer's, depression, diabetes, and cancer. Non-invasive diagnostic methods are needed to reliably detect these disorders. Until now, radioactive substances have been used to map glucose metabolism in the brain. However, a research team at MedUni Vienna has developed a new MRI approach that uses a harmless glucose solution to generate reliable results. This new method can be used with all common MRI scanners and has been published in the scientific journal Nature Biomedical Engineering. 

The research team conducted a study to improve current diagnostic methods for mapping brain glucose metabolism. They measured blood glucose levels and metabolic products in healthy subjects multiple times over 90 minutes, using a harmless glucose solution instead of radiolabeled glucose. This method indirectly measured the concentrations and metabolism of glucose based on changes in signal intensity for the product. Unlike other approaches, this method does not require additional hardware components, making it easy to use with other MRI devices. Wolfgang Bogner from MedUni Vienna explained the significance of this finding for clinical practice. 

 

Broad Range of Potential Applications 

The study was conducted by researchers from the Department of Psychiatry and Psychotherapy and the Department of Medicine III at MedUni Vienna, using the university's 7-Tesla MRI scanner, which is the only ultra-high-field MR scanner in Austria. The researchers were able to demonstrate that their new approach also works on 3-Tesla MR scanners, which are commonly used in clinical applications. This finding was an important step in validating the practicality and widespread applicability of the new method. Fabian Niess, the lead author of the follow-up study, highlighted the significance of this development. 

 

Further Studies Needed to Confirm Results 

Many common diseases are characterized by abnormalities in glucose metabolism. For example, cancer and tumor cells consume more glucose than normal cells, which is used in diagnosing and locating tumors through PET-CT scans. However, this requires injecting patients with radioactive glucose. While the new, less invasive MRI method developed at MedUni Vienna shows promise, further studies are needed to validate its effectiveness before it can be used for patient benefit. 

For more information: https://www.meduniwien.ac.at/web/ 


Related Content

News | Pediatric Imaging

November 29, 2023 — Using artificial intelligence (AI) to analyze specialized brain MRI scans of adolescents with and ...

Time November 29, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

November 29, 2023 — Researchers have identified objective evidence of how the neck muscles are involved in primary ...

Time November 29, 2023
arrow
News | Artificial Intelligence

November 28, 2023 — Combining Vista.ai's leading radiology AI-guided software that automates MRI exams for quick and ...

Time November 28, 2023
arrow
News | Digital Radiography (DR)

November 28, 2023 — Canon Medical Components USA (CMCU) - Digital Radiography (DR), global leaders in advanced flat ...

Time November 28, 2023
arrow
News | RSNA

November 28, 2023 — New research being presented this week at the annual meeting of the Radiological Society of North ...

Time November 28, 2023
arrow
News | Computed Tomography (CT)

November 28, 2023 — Smoking marijuana in combination with cigarettes may lead to increased damage of the lung’s air sacs ...

Time November 28, 2023
arrow
News | RSNA

November 27, 2023 — The executive leadership teams from Canon Inc. and Cleveland Clinic gathered early on day two of the ...

Time November 27, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

November 27, 2023 — SyntheticMR announced that its next-generation imaging solution with isotropic resolution, SyMRI 3D ...

Time November 27, 2023
arrow
News | Radiation Dose Management

November 27, 2023 — Qaelum NV, a leading provider of innovative healthcare solutions, and Philips, a global leader in ...

Time November 27, 2023
arrow
News | RSNA

November 27, 2023 — Black patients underwent medical imaging for cognitive impairment years later than white and ...

Time November 27, 2023
arrow
Subscribe Now